Ultrasound and Proteomics for Guselkumab Response Assessment in Crohn's Disease (UPGRADE).
NCT07246460
·
clinicaltrials.gov ↗
RECRUITING
Status
90
Enrollment
OTHER
Sponsor class
Conditions
Crohn's Disease of Both Small and Large Intestine
Interventions
DRUG:
Guselkumab Subcutaneous
Sponsor
University of Calgary